Total Payments
$3,399
2024 Payments
$41.42
Companies
27
Transactions
168
Medicare Patients
11,484
Medicare Billing
$866,318
Payment Breakdown by Category
Food & Beverage$2,847 (83.8%)
Travel$545.88 (16.1%)
Education$6.25 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,847 | 166 | 83.8% |
| Travel and Lodging | $545.88 | 1 | 16.1% |
| Education | $6.25 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $743.27 | 9 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $501.15 | 37 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $351.73 | 22 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $328.05 | 26 | $0 (2023) |
| Amgen Inc. | $204.39 | 9 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $181.89 | 15 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $158.81 | 10 | $0 (2019) |
| Allergan Inc. | $139.44 | 1 | $0 (2017) |
| Braemar Manufacturing, LLC | $121.81 | 2 | $0 (2018) |
| Abbott Laboratories | $114.60 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.42 | 2 | Recor Medical Inc ($24.93) |
| 2023 | $76.79 | 3 | E.R. Squibb & Sons, L.L.C. ($32.41) |
| 2022 | $40.87 | 2 | Dompe US, Inc. ($21.78) |
| 2019 | $320.03 | 17 | Abbott Laboratories ($95.39) |
| 2018 | $777.05 | 49 | E.R. Squibb & Sons, L.L.C. ($170.32) |
| 2017 | $2,143 | 95 | Medtronic Vascular, Inc. ($712.58) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 6 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2017 | Medtronic Vascular, Inc. | Advisa (Device) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Pacemakers | ||||||
| 04/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2017 | Medtronic Vascular, Inc. | Advisa (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Pacemakers | ||||||
| 04/11/2017 | Medtronic Vascular, Inc. | SelectSecure (Device) | Travel and Lodging | In-kind items and services | $545.88 | General |
| Category: Leads | ||||||
| 04/11/2017 | Medtronic Vascular, Inc. | Advisa (Device) | Food and Beverage | In-kind items and services | $90.69 | General |
| Category: Pacemakers | ||||||
| 04/11/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.59 | General |
| Category: Cardiovascular | ||||||
| 04/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | Cash or cash equivalent | $6.25 | General |
| Category: Cardiovascular | ||||||
| 04/10/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2017 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Cardiology | ||||||
| 04/03/2017 | Biosense Webster, Inc. | Carto 3 System (Device) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Cardiology | ||||||
| 03/31/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/30/2017 | BOSTON SCIENTIFIC CORPORATION | EMBLEM S-ICD (Device) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: TACHY SYSTEM | ||||||
| 03/27/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Cardiovascular | ||||||
| 03/18/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $91.00 | General |
| 03/17/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/09/2017 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/09/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,551 | 5,976 | $819,002 | $202,876 |
| 2022 | 35 | 2,710 | 6,216 | $842,727 | $207,921 |
| 2021 | 32 | 2,802 | 6,663 | $916,137 | $232,012 |
| 2020 | 33 | 3,421 | 6,411 | $902,901 | $223,509 |
Total Patients
11,484
Total Services
25,266
Medicare Billing
$866,318
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 337 | $108,851 | $30,911 | 28.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 287 | 875 | $91,000 | $18,639 | 20.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 105 | 637 | $66,248 | $17,446 | 26.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 352 | 1,076 | $82,852 | $16,670 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 101 | 121 | $52,756 | $15,819 | 30.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 115 | 118 | $49,442 | $12,194 | 24.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 83 | 643 | $53,175 | $12,098 | 22.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 129 | 204 | $35,700 | $11,347 | 31.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 26 | 26 | $43,680 | $10,540 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 90 | 122 | $26,840 | $7,652 | 28.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 60 | $19,140 | $5,779 | 30.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 68 | 207 | $42,849 | $5,499 | 12.8% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 12 | 12 | $18,336 | $4,660 | 25.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 30 | 224 | $18,778 | $4,380 | 23.3% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 45 | 67 | $13,802 | $4,161 | 30.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $17,360 | $3,930 | 22.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 253 | 340 | $17,340 | $3,698 | 21.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 25 | 42 | $11,424 | $3,181 | 27.8% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 11 | 11 | $12,452 | $2,904 | 23.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 190 | 427 | $4,330 | $2,733 | 63.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 45 | 45 | $5,400 | $1,824 | 33.8% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 14 | 23 | $5,635 | $1,615 | 28.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 60 | 65 | $4,810 | $1,193 | 24.8% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 19 | 26 | $3,276 | $1,116 | 34.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 26 | 27 | $3,024 | $1,090 | 36.0% |
About Dr. James Walsh, MD
Dr. James Walsh, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437152600.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Walsh, MD has received a total of $3,399 in payments from pharmaceutical and medical device companies, with $41.42 received in 2024. These payments were reported across 168 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,847).
As a Medicare-enrolled provider, Walsh has provided services to 11,484 Medicare beneficiaries, totaling 25,266 services with total Medicare billing of $866,318. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Clinical Cardiac Electrophysiology
- Location Jacksonville, FL
- Active Since 05/23/2005
- Last Updated 05/28/2014
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1437152600
Products in Payments
- SelectSecure (Device) $545.88
- XARELTO (Drug) $501.15
- ELIQUIS (Drug) $357.12
- ENTRESTO (Drug) $351.73
- LifeVest (Device) $181.89
- Advisa (Device) $166.70
- DALVANCE (Drug) $139.44
- Cardiac Monitoring Suite (Device) $121.81
- Mitra Clip system (Device) $95.39
- MULTAQ (Drug) $85.91
- Corlanor (Drug) $73.44
- PRALUENT (Drug) $72.90
- BRILINTA (Drug) $66.61
- PRALUENT ALIROCUMAB INJECTION (Biological) $40.00
- Repatha (Biological) $39.95
- WATCHMAN (Device) $32.74
- CAMZYOS (Drug) $32.41
- PRADAXA (Drug) $30.66
- FFRct (Device) $27.52
- DyeVert (Device) $25.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Jacksonville
Dr. Matthew Mckillop, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $141,821
Clinical Cardiac Electrophysiology $141,821
Dr. Aaditya Vora, Md, MD
Clinical Cardiac Electrophysiology — Payments: $89,405
Clinical Cardiac Electrophysiology $89,405
Dr. Aditya Saini, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $49,187
Clinical Cardiac Electrophysiology $49,187
Danesh Kella, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $35,874
Clinical Cardiac Electrophysiology $35,874
Amr Barakat, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $35,002
Clinical Cardiac Electrophysiology $35,002
Dr. Steven Ross, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $25,760
Clinical Cardiac Electrophysiology $25,760